JAMES POOL to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications JAMES POOL has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.302
-
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. Am J Hypertens. 1997 Jan; 10(1):117-23.
Score: 0.119
-
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. Am J Med. 1988 Sep 23; 85(3B):19-24.
Score: 0.067
-
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987; 9 Suppl 3:S36-42.
Score: 0.059
-
Lovastatin and coadministered antihypertensive/cardiovascular agents. Hypertension. 1992 Mar; 19(3):242-8.
Score: 0.021
-
Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991 Sep; 122(3 Pt 2):926-31.
Score: 0.021
-
Pharmacology of angiotensin converting enzyme inhibitors. A review. Am J Med. 1986 Oct 31; 81(4C):13-8.
Score: 0.015